Stefan Heller

Stefan Heller has been a Scientific Advisor for Lineage Cell Therapeutics since 2022, Director for Avelas Biosciences, Inc., Fortis Therapeutics, Inc., Nerio Therapeutics, Inc., Janux Therapeutics, and Adanate since 2019, and Scientific Advisor for Inception Therapeutics since 2012. Stefan has also been a Professor at Stanford University School of Medicine since 2005 and held various roles including Professor, Institute for Stem Cell Biology and Regenerative Medicine, Vice Chair for Research, Department of Otolaryngology – Head & Neck Surgery, Edward C. and Amy H. Sewall Professor, Affiliate Professor, Institute for Stem Cell Biology and Regenerative Medicine, Professor, by courtesy, of Molecular and Cellular Physiology, Associate Professor, by courtesy, of Molecular and Cellular Physiology, and Associate Professor of Otolaryngology – Head & Neck Surgery.

Stefan Heller has an extensive education history. From 1985 to 1991, they attended Johannes Gutenberg University Mainz and obtained a Master of Science in Biology. From 1991 to 1994, they studied at JGU and Max Planck Institute for Brain Research and received a PhD in Genetics. From 1994 to 1995, they were a Postdoctoral Fellow at Max-Planck Institute for Brain Research, studying Developmental Neurobiology. From 1995 to 2000, they were a Postdoctoral Fellow at The Rockefeller University, studying Molecular Sensory Neuroscience. In 2006, they obtained a Faculty Affiliate certification from Stanford Biosciences Graduate Programs.